RECRUITINGOBSERVATIONAL
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
About This Trial
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Who May Be Eligible (Plain English)
Who May Qualify:
- Biopsy proven sarcoidosis
- Suspected cardiac sarcoidosis
Who Should NOT Join This Trial:
- Contraindication to MRI
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Biopsy proven sarcoidosis
* Suspected cardiac sarcoidosis
Exclusion Criteria:
* Contraindication to MRI
Locations (1)
Duke University Medical Center
Durham, North Carolina, United States